home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Thermo Fisher Scientific (NY:TMO)

496.55 +5.02 (+1.02%)

Streaming Delayed Price Updated: 10:11 AM EDT, Apr 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Thermo Fisher Scientific

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

32 33 Next >

Winners And Losers Of Q4: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks

March 03, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Revvity (NYSE:RVTY) and the best and worst...

Via StockStory

Topics Economy

Trian Comments on Solventum’s Sale of its Purification & Filtration Business

February 26, 2025

From Trian Fund Management, L.P.

Via GlobeNewswire

Dan Loeb Adjusts Healthcare Holdings: Danaher Stake Trimmed As Thermo Fisher Gains Favor ↗

February 25, 2025

Loeb's Third Point LLC restructured their portfolio in last quarter of 2024. They decreased stake in Danaher Corp. and acquired stake in Thermo Fisher.

Via Benzinga

Thermo Fisher Bets Big On Bioproduction With Solventum's Unit Deal Worth $4.1 Billion ↗

February 25, 2025

Thermo Fisher will acquire Solventum's Purification & Filtration business for $4.1 billion, expanding its bioproduction portfolio with expected long-term growth.

Via Benzinga

Thermo Fisher Scientific Unusual Options Activity ↗

February 21, 2025

Via Benzinga

Looking Into Thermo Fisher Scientific's Recent Short Interest ↗

February 20, 2025

Via Benzinga

$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today ↗

February 03, 2025

Via Benzinga

Thermo Fisher Scientific to Acquire Solventum’s Purification and Filtration Business

February 25, 2025

From Thermo Fisher Scientific Inc.

Via Business Wire

Thermo Fisher Scientific to Present at TD Cowen 45th Annual Health Care Conference on March 3, 2025

February 24, 2025

From Thermo Fisher Scientific Inc.

Via Business Wire

Thermo Fisher Scientific Increases Quarterly Dividend

February 19, 2025

From Thermo Fisher Scientific Inc.

Via Business Wire

Thermo Fisher Scientific Elects New Director to Board

February 19, 2025

From Thermo Fisher Scientific Inc.

Via Business Wire

Analyst Expectations For Thermo Fisher Scientific's Future ↗

January 31, 2025

Via Benzinga

Smart Money Is Betting Big In TMO Options ↗

January 29, 2025

Via Benzinga

Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 15 Years ↗

February 18, 2025

Via Benzinga

3 Healthcare Stocks Skating on Thin Ice

February 12, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But near-term speed bumps have persisted in the wake of COVID-19 as players destocked inventories in 2023 and...

Via StockStory

Topics Stocks

Uncover the latest developments among S&P500 stocks in today's session. ↗

February 10, 2025

Curious about the top performers within the S&P500 index in the middle of the day on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

Via Chartmill

Gapping S&P500 stocks in Monday's session ↗

February 10, 2025

Let's have a look at the S&P500 gap up and gap down stocks in today's session.

Via Chartmill

Thermo Fisher Scientific Accelerates 100 Percent Renewable Electricity Goal for European Operations with New Solar Power Agreement with X-ELIO

February 04, 2025

From Thermo Fisher Scientific Inc.

Via Business Wire

Thermo Fisher’s (NYSE:TMO) Q4 Sales Beat Estimates

January 30, 2025

Life sciences company Thermo Fisher (NYSE:TMO) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 4.7% year on year to $11.4 billion. Its non-GAAP profit of $6.10 per...

Via StockStory

Topics Earnings

Top S&P500 movers in Thursday's session ↗

January 30, 2025

Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Thursday.

Via Chartmill

Explore the top gainers and losers within the S&P500 index in today's session. ↗

January 30, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

Thermo Fisher Scientific (TMO) Q4 2024 Earnings Call Transcript ↗

January 30, 2025

TMO earnings call for the period ending December 31, 2024.

Via The Motley Fool

Topics Earnings

Thermo Fisher Scientific Gaps Up, Nearing A Buy Point, On Strong Earnings Beat ↗

January 30, 2025

Shares of Thermo Fisher Scientific surged Thursday after the life sciences titan beat Wall Street's fourth-quarter forecasts.

Via Investor's Business Daily

Thursday's session: gap up and gap down stock in the S&P500 index ↗

January 30, 2025

Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Thursday. Stay informed about the latest market trends.

Via Chartmill

Thermo Fisher Q4 Earnings Beat Estimates, Margin Expands ↗

January 30, 2025

Thermo Fisher Scientific (TMO) reports Q4 earnings of $6.10 per share, exceeding expectations. Operating income and revenue growth also increased.

Via Benzinga

Topics Earnings

Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2024 Results

January 30, 2025

From Thermo Fisher Scientific Inc.

Via Business Wire

Earnings Scheduled For January 30, 2025 ↗

January 30, 2025

Via Benzinga

9 Health Care Stocks With Whale Alerts In Today's Session ↗

January 28, 2025

Via Benzinga

Morgan Stanley Reveals Top 20 AI-Driven Stocks as Adoption Hits Critical Mass ↗

January 26, 2025

Katy Huberty, the Global Head of Research at Morgan Stanley, has spotlighted 20 stocks from companies that are likely to see significant benefits from the adoption of Artificial Intelligence (AI).

Via Benzinga

Topics Artificial Intelligence

Goldman Sachs Predicts Gradual Recovery For Tools And Contract Research Sector In 2025, Stable Large Pharma Spending Key To Recovery ↗

January 24, 2025

Goldman Sachs predicts a gradual recovery for Life Sciences Tools in 2025, with bioprocessing gaining traction and improved investor sentiment likely.

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

32 33 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com